Which medications in the drug class Retinoids are used in the treatment of Dermatologic Manifestations of Kaposi Sarcoma?

Updated: Mar 26, 2021
  • Author: Robert A Schwartz, MD, MPH; Chief Editor: Dirk M Elston, MD  more...
  • Print


Retinoids decrease cohesiveness of abnormal hyperproliferative keratinocytes and may reduce the potential for malignant degeneration. They modulate keratinocyte differentiation and have been shown to reduce the risk of skin cancer formation in renal transplantation patients.

Alitretinoin topical

Alitretinoin topical is a 0.1% gel. It is a topical treatment for cutaneous lesions. Alitretinoin is a naturally occurring endogenous retinoid. It inhibits the growth of Kaposi sarcoma by binding to retinoid receptors.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!